Inhibrx Biosciences (INBX) EBT (2023 - 2025)
Inhibrx Biosciences' (INBX) quarterly EBT came in at -$32.8 million in Q4 2025, up 31.4% year-on-year from -$25.0 million in Q4 2024, and up 6.87% on a QoQ basis from -$35.3 million in Q3 2025.
Inhibrx Biosciences (INBX) EBT (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of EBT data on file, last reported at -$32.8 million in Q4 2025.
- On a quarterly basis, EBT rose 31.4% year-over-year to -$32.8 million in Q4 2025; TTM through Dec 2025 was -$140.1 million, a 108.3% decrease from a year earlier, with the FY2025 full-year figure at -$140.1 million, down 108.3% from the prior year.
- EBT for Q4 2025 stood at -$32.8 million, up from -$35.3 million in the prior quarter.
- Over the last five years, EBT for INBX reached as high as $1.9 billion in Q2 2024 and fell as low as -$92.0 million in Q4 2023.
- Historically, EBT has averaged $123.3 million across 3 years, with a median of -$43.9 million in 2024.
- Across the five-year window, EBT soared 4049.27% in 2024 and sank 101.54% in 2025, its largest moves.
- Year by year, EBT stood at -$92.0 million in 2023, then soared by 47.96% to -$47.9 million in 2024, then soared by 31.4% to -$32.8 million in 2025.
- Per Business Quant data, the three most recent EBT figures were -$32.8 million in Q4 2025, -$35.3 million in Q3 2025, and -$28.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Inhibrx Biosciences | 1.32 Bn | 1.32 Bn | - | -32.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.83 Mn |
| Sep 30, 2025 | -35.26 Mn |
| Jun 30, 2025 | -28.65 Mn |
| Mar 31, 2025 | -43.31 Mn |
| Dec 31, 2024 | -47.87 Mn |
| Sep 30, 2024 | -43.86 Mn |
| Jun 30, 2024 | 1.86 Bn |
| Mar 31, 2024 | -78.71 Mn |
| Dec 31, 2023 | -91.97 Mn |
| Sep 30, 2023 | -51.79 Mn |
| Jun 30, 2023 | -47.05 Mn |